Co-administration of insulin glargine with oral therapy in patients with Type 2 diabetes allows flexible dosing and improved glycaemic control with reduced hypoglycaemia compared with NPH insulin.

被引:0
|
作者
Busch, K
Fritsche, A
Häring, HU
Schweitzer, MA
Vesper, I
机构
[1] Praxis, Dortmund, Germany
[2] Med Universitatsklin, Tubingen, Germany
[3] Aventis Pharma Deutschland GmbH, Frankfurt, Germany
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
10
引用
收藏
页码:A6 / A6
页数:1
相关论文
共 50 条